Qinghai Spring Medicinal Resources Technology Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 160.71 million compared to CNY 128.65 million a year ago. Revenue was CNY 160.71 million compared to CNY 128.65 million a year ago.

Net loss was CNY 70.33 million compared to CNY 75.4 million a year ago. Basic loss per share from continuing operations was CNY 0.12 compared to CNY 0.128 a year ago. Diluted loss per share from continuing operations was CNY 0.12 compared to CNY 0.128 a year ago.